rs16886258
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000322507.13(COL12A1):āc.834T>Gā(p.Ala278=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,612,462 control chromosomes in the GnomAD database, including 90 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.013 ( 41 hom., cov: 33)
Exomes š: 0.0014 ( 49 hom. )
Consequence
COL12A1
ENST00000322507.13 synonymous
ENST00000322507.13 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.695
Genes affected
COL12A1 (HGNC:2188): (collagen type XII alpha 1 chain) This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 6-75188525-A-C is Benign according to our data. Variant chr6-75188525-A-C is described in ClinVar as [Benign]. Clinvar id is 259352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-75188525-A-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.695 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0133 (2028/152242) while in subpopulation AFR AF= 0.0465 (1934/41556). AF 95% confidence interval is 0.0448. There are 41 homozygotes in gnomad4. There are 973 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 41 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL12A1 | NM_004370.6 | c.834T>G | p.Ala278= | synonymous_variant | 8/66 | ENST00000322507.13 | NP_004361.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL12A1 | ENST00000322507.13 | c.834T>G | p.Ala278= | synonymous_variant | 8/66 | 1 | NM_004370.6 | ENSP00000325146 | P4 | |
COL12A1 | ENST00000345356.10 | c.73+14195T>G | intron_variant | 1 | ENSP00000305147 | |||||
COL12A1 | ENST00000483888.6 | c.834T>G | p.Ala278= | synonymous_variant | 8/65 | 5 | ENSP00000421216 | A1 | ||
COL12A1 | ENST00000416123.6 | c.834T>G | p.Ala278= | synonymous_variant | 7/63 | 5 | ENSP00000412864 |
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 2022AN: 152124Hom.: 41 Cov.: 33
GnomAD3 genomes
AF:
AC:
2022
AN:
152124
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00355 AC: 879AN: 247726Hom.: 24 AF XY: 0.00271 AC XY: 364AN XY: 134434
GnomAD3 exomes
AF:
AC:
879
AN:
247726
Hom.:
AF XY:
AC XY:
364
AN XY:
134434
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00141 AC: 2055AN: 1460220Hom.: 49 Cov.: 31 AF XY: 0.00117 AC XY: 849AN XY: 726430
GnomAD4 exome
AF:
AC:
2055
AN:
1460220
Hom.:
Cov.:
31
AF XY:
AC XY:
849
AN XY:
726430
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0133 AC: 2028AN: 152242Hom.: 41 Cov.: 33 AF XY: 0.0131 AC XY: 973AN XY: 74434
GnomAD4 genome
AF:
AC:
2028
AN:
152242
Hom.:
Cov.:
33
AF XY:
AC XY:
973
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2019 | - - |
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at